| Douglas Pollard, MD | |
|
15 Hospital Dr, York, ME 03909-1011 | |
| (207) 351-2478 | |
| (207) 351-2216 |
| Full Name | Douglas Pollard |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 37 Years |
| Location | 15 Hospital Dr, York, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710969803 | NPI | - | NPPES |
| 3065774 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 70467 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health | Portsmouth, NH | Home health agency |
| York Hospital Home Care | York, ME | Home health agency |
| Elara Caring | Kittery, ME | Home health agency |
| Beacon Hospice, An Amedisys Company | Portsmouth, NH | Hospice |
| York Hospital | York, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| York Hospital | 6406766781 | 169 |
News Archive
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
The prostate cancer charter for change from 13 influential European and US prostate cancer patient groups, calls for the disease to be treated with the same level of priority as breast cancer is in women.
Researchers at the Centre for Addiction and Mental Health have identified 428 distinct disease conditions that co-occur in people with Fetal Alcohol Spectrum Disorders (FASD), in the most comprehensive review of its kind.
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
› Verified 2 days ago
| Entity Name | York Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376528398 PECOS PAC ID: 6406766781 Enrollment ID: O20040812001065 |
News Archive
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
The prostate cancer charter for change from 13 influential European and US prostate cancer patient groups, calls for the disease to be treated with the same level of priority as breast cancer is in women.
Researchers at the Centre for Addiction and Mental Health have identified 428 distinct disease conditions that co-occur in people with Fetal Alcohol Spectrum Disorders (FASD), in the most comprehensive review of its kind.
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas Pollard, MD 2 Hospital Dr, Ste A, York, ME 03909-1011 Ph: () - | Douglas Pollard, MD 15 Hospital Dr, York, ME 03909-1011 Ph: (207) 351-2478 |
News Archive
ActiveCare, Inc. and Vista Therapeutics, Inc. announced today a strategic relationship to develop Nano Biosensors for ActiveCare's products and services to be utilized by the elderly. These Biosensors will allow ActiveCare to continuously monitor specific chronic diseases commonly occurring in the elderly and thus preventively predict and avoid acute medical events. "This technology is designed to prolong and improve the quality of life of our senior population," stated James Dalton, President of ActiveCare.
The prostate cancer charter for change from 13 influential European and US prostate cancer patient groups, calls for the disease to be treated with the same level of priority as breast cancer is in women.
Researchers at the Centre for Addiction and Mental Health have identified 428 distinct disease conditions that co-occur in people with Fetal Alcohol Spectrum Disorders (FASD), in the most comprehensive review of its kind.
TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have proceeded through early preclinical development and were granted "Investigative New Drug" status by the U.S. Food and Drug Administration. The phase 1 clinical trials are presently ongoing.
› Verified 2 days ago
Catherine Stehman-breen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Meetinghouse Ln, York, ME 03909 Phone: 207-361-4566 | |
Dr. Evangeline Thibodeau, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Hospital Dr, Ste A, York, ME 03909 Phone: 207-351-3530 | |
Dr. Joel William Keenan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Brickyard Ln, Suite Cc, York, ME 03909 Phone: 207-361-4902 Fax: 207-363-2505 | |
Lawrence J Petrovich, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12 Hospital Dr, Suite 9, York, ME 03909 Phone: 207-363-6136 Fax: 207-363-4863 | |
Thomas Gordon Chayka, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 50 Old Post Road, York, ME 03909 Phone: 207-363-5321 Fax: 207-363-7857 | |
Gretchen Volpe, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12 Hospital Dr, Suite B, York, ME 03909 Phone: 207-351-3530 Fax: 207-351-3574 | |
Colleen K. Yavarow, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 127 Long Sands Rd, York, ME 03909 Phone: 207-351-3777 |